Alan Ó Céilleachair1, Paul Hanly2, Máiréad Skally3, Eamonn O'Leary3, Ciaran O'Neill4, Patricia Fitzpatrick5, Kanika Kapur6, Anthony Staines7, Linda Sharp8. 1. National Cancer Registry Ireland, Building 6800, Cork Airport Business Park, Cork, Ireland. a.oceilleachair@ncri.ie. 2. National College of Ireland, IFSC, Dublin 1, Ireland. 3. National Cancer Registry Ireland, Building 6800, Cork Airport Business Park, Cork, Ireland. 4. National University of Ireland, Galway, Ireland. 5. School of Public Health, Physiotherapy & Population Science, University College Dublin, Dublin 4, Ireland. 6. School of Economics and Geary Institute, University College Dublin, Dublin 4, Ireland. 7. School of Nursing and Human Sciences, Dublin City University, Dublin 9, Ireland. 8. Institute of Health & Society, Newcastle University, Newcastle, UK.
Abstract
PURPOSE: Cancer places a significant cost burden on health services. There is increasing recognition that cancer also imposes a financial and economic burden on patients but this has rarely been quantified outside North America. We investigate out-of-pocket costs (OOPCs) incurred by colorectal (CRC) survivors in Ireland. METHODS: CRC survivors (ICD10 C18-20) diagnosed 6-30 months previously were identified from the National Cancer Registry Ireland and invited to complete a postal questionnaire. Cancer-related OOPC for tests, procedures, drugs, allied medications and household management in approximately the year following diagnosis were calculated. Robust regression was used to identify predictors of OOPC; this was done for all survivors combined and stratified by age (<70 and ≥70 years) and employment status (working and not working) at diagnosis. RESULTS: Four hundred ninety-seven CRC survivors completed questionnaires (response rate = 39%). Almost all (90%) respondents reported some cancer-related OOPC. The average total OOPC was €1589. Stage III at diagnosis was associated with significantly higher OOPCs than other stages in the all-survivor model, in those not working in the employment model and in those under 70 years in the age-stratified model. In all-survivor model, those under 70 also had higher OOPCs, as did those in employment. Having one or more children was associated with significantly lower OOPCs in those under 70 years. CONCLUSIONS: Almost all CRC survivors incur cancer-related OOPCs; for some, these are not insignificant. Greater attention should be paid to the development of services to help survivors manage the financial and economic burden of cancer.
PURPOSE:Cancer places a significant cost burden on health services. There is increasing recognition that cancer also imposes a financial and economic burden on patients but this has rarely been quantified outside North America. We investigate out-of-pocket costs (OOPCs) incurred by colorectal (CRC) survivors in Ireland. METHODS: CRC survivors (ICD10 C18-20) diagnosed 6-30 months previously were identified from the National Cancer Registry Ireland and invited to complete a postal questionnaire. Cancer-related OOPC for tests, procedures, drugs, allied medications and household management in approximately the year following diagnosis were calculated. Robust regression was used to identify predictors of OOPC; this was done for all survivors combined and stratified by age (<70 and ≥70 years) and employment status (working and not working) at diagnosis. RESULTS: Four hundred ninety-seven CRC survivors completed questionnaires (response rate = 39%). Almost all (90%) respondents reported some cancer-related OOPC. The average total OOPC was €1589. Stage III at diagnosis was associated with significantly higher OOPCs than other stages in the all-survivor model, in those not working in the employment model and in those under 70 years in the age-stratified model. In all-survivor model, those under 70 also had higher OOPCs, as did those in employment. Having one or more children was associated with significantly lower OOPCs in those under 70 years. CONCLUSIONS: Almost all CRC survivors incur cancer-related OOPCs; for some, these are not insignificant. Greater attention should be paid to the development of services to help survivors manage the financial and economic burden of cancer.
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Laura-Mae Baldwin; Yong Cai; Eric H Larson; Sharon A Dobie; George E Wright; David C Goodman; Barbara Matthews; L Gary Hart Journal: J Rural Health Date: 2008 Impact factor: 4.333
Authors: Jade C Newton; Claire E Johnson; Harry Hohnen; Max Bulsara; Angela Ives; Sandy McKiernan; Violet Platt; Ruth McConigley; Neli S Slavova-Azmanova; Christobel Saunders Journal: Support Care Cancer Date: 2018-04-27 Impact factor: 3.603
Authors: Christopher J Longo; Margaret I Fitch; Jonathan M Loree; Linda E Carlson; Donna Turner; Winson Y Cheung; Darin Gopaul; Janet Ellis; Jolie Ringash; Maria Mathews; Jim Wright; Christiaan Stevens; David D'Souza; Robin Urquhart; Tuhin Maity; Fanor Balderrama; Evette Haddad Journal: Support Care Cancer Date: 2021-01-05 Impact factor: 3.603
Authors: Frederike E C M Mulder; Eline H van Roekel; Martijn J L Bours; Matty P Weijenberg; Silvia M A A Evers Journal: J Cancer Surviv Date: 2021-09-11 Impact factor: 4.062
Authors: Matthias Büttner; Susanne Singer; Leopold Hentschel; Stephan Richter; Peter Hohenberger; Bernd Kasper; Dimosthenis Andreou; Daniel Pink; Kathy Taylor; Karin Arndt; Martin Bornhäuser; Jochen Schmitt; Markus K Schuler; Martin Eichler Journal: Support Care Cancer Date: 2021-07-11 Impact factor: 3.603